Ann: US$35m Committed Offer of Debt Funding Secured, page-10

First 10 Last

Share
Profile

Follow
dphongthai

270 Posts.

61

19/10/18

16:46

Post #: 36190933
Share

Originally posted by Zestfulmocha ↑

The principal loan amount outstanding can also be converted into shares in Vector, from completion of the DFS and subject to shareholder approval, with the initial US$5m Tranche 1 amount converting at a 25% premium to the Company’s 10-day VWAP share price (5 days before and 5 days after the drawdown date);

^ This will be interest to watch for, if the chose to convert to shares @25% premium to current 5 day VWAP (which if the deal was signed today and loans applied, means they'll be able to effectively buy VEC shares at 2.5-2.6c, so this will effectively be a CR at a 25% premium - which is great, excluding the fact the share price is absolutely rubbished right now, but any CR performed at these levels would probably be getting in for 18-20+ anyway... so I think this is a better option than none to have on the table, and I think hats off to Jason for securing that arrangement as opposed to a CR @ discount% approach which I guess would be considered the norm.... so the two outcomes are either a CR at a premium (great) or no dilution yet secured funding (great, but will have to repaid, soo.... CR eventually anyway?).

Will be a good outcome if they convert to shares IMO as I think it'll be a vote of confidence in what they're funding, and will prove this whole funding arrangement was just a deal for them to get a stake and at a premium - this is perhaps the benefit of having so many 'competing offers.

Just musing, I think it would be a good out come for the company, some will complain about dilution but it'll be hard to complain about the premium, so all in all, another thing I hadn't previously fully digested which I like to see.

Expand

Zesty, this is an option for FT General to convert the debt to equity in the future. Not now, but after the DFS is done. And yes, at a premium

VEC Price at posting: 2.1¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

First 10 Last

Add VEC (ASX) to my watchlist

Ann: US$35m Committed Offer of Debt Funding Secured, page-10

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News